Vimarsana
Biggest News Aggregation in the World

Page 5 - Augmented Generation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Augmented Generation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Augmented Generation Today - Breaking & Trending Today

Know before you go: 6 lessons for enterprise GenAI adoption - Vimarsana News

Know before you go: 6 lessons for enterprise GenAI adoption

We get it. The generative AI hype is real—indicating its transformative potential. However, enterprises need a purpose-built GenAI approach to ensure proper deployment and mitigate serious risks.

Source: cio.com
Must-Read Best Of Practical Prompt Engineering Strategies To Become A Skillful Prompting Wizard In Generative AI - Vimarsana News

Must-Read Best Of Practical Prompt Engineering Strategies To Become A Skillful Prompting Wizard In Generative AI

This is a recap compilation of my extensive coverage about prompt engineering strategies and techniques. Use this to gauge what you know and don't know about prompting.

Source: forbes.com
KX Counts In Time-Orientated Generative AI - Vimarsana News

KX Counts In Time-Orientated Generative AI

Generative AI continues to develop and its alignment to time-series & time-specific data workloads makes logical sense in terms of its wider evolution and development.

Source: forbes.com
Redis Cloud Leverages Amazon Bedrock to Deliver Speed and Reliability to Retrieval Augmented Generation Architectures - Vimarsana News

Redis Cloud Leverages Amazon Bedrock to Deliver Speed and Reliability to Retrieval Augmented Generation Architectures

Redis, Inc. announced it is furthering developers ability to harness Redis Cloud as a vector database...

ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ImmunoPrecise Antibodies (NASDAQ:IPA) - Vimarsana News

ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ImmunoPrecise Antibodies (NASDAQ:IPA)

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, has announced that its subsidiary, BioStrand®, has launched an advanced Retrieval Augmented Generation (RAG)-based Large Language Model (LLM) platform.